FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Lions lock up star defensive end Aidan Hutchinson with record-breaking $180M extension
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Lions lock up star defensive end Aidan Hutchinson with record-breaking $180M extension